Anne C. Andorn

Anne C. Andorn, M.D., is a Board Certified psychiatrist with additional fellowship training in clinical pharmacology and pharmacology. Dr. Andorn spent the first half of her career in academic medicine where she taught, cared for patients, and conducted neuroscience research. The second half of her career has been spent in the pharmaceutical industry with positions of increasing responsibility at companies including Eli Lilly and Company, GlaxoSmithKline, Pfizer, and others. In these roles, Dr. Andorn has conducted translational, early-phase, and late-phase drug development. In these positions, she has interfaced with commercial and medical affairs colleagues and has previously served as a CMO.

Dr. Andorn received her medical degree from The Ohio State University College of Medicine and completed her residency and fellowship training at Case Western Reserve University School of Medicine.